Skip to content

Impact of Food Assistance on Treatment Adherence and Clinical Outcomes in Food-Insecure Cancer Pts

Impact of Food Assistance on Treatment Adherence and Clinical Outcomes in Food-Insecure Cancer Patients Undergoing Active Treatment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07706192
Enrollment
350
Registered
2026-07-15
Start date
2026-07-06
Completion date
2035-08-31
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment Adherence

Keywords

Treatment Adherence, Food Insecurity, Cancer Patients on Active Treatment

Brief summary

Prospective cohort and descriptive study aimed at identifying cancer patients experiencing food insecurity at Virginia Commonwealth University (VCU) Massey Comprehensive Cancer Center. The study will involve evaluating the impact of a food assistance intervention on treatment adherence and clinical outcomes among food-insecure patients on active treatment.

Interventions

OTHERFood Assistance Program

Participants will be enrolled and provided with structured food assistance (e.g., shelf stable food boxes, produce vouchers) for six months

OTHERStandard of Care

Participants who receive usual-care referrals but not food packages.

Sponsors

Virginia Commonwealth University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients (≥18 years old) with a current diagnosis of cancer * Patients attending outpatient services at the VCU Massey Comprehensive Cancer Center * Patients who are willing to participate and provide informed consent * Responding "sometimes true" or "often true" to at least one of the two validate Hunger Vital Sign Screening questions

Exclusion criteria

* Patients who are unable to provide informed consent due to cognitive impairment or language barriers * Patients who are enrolled in other clinical trials that prohibit participation in additional research * Patients who do not consent to being included in the food insecurity registry * Patients with medical conditions other than cancer

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the impact of a food assistance intervention on treatment adherence and clinical outcomes among food-insecure patients on active treatment.6 months following enrollmentPercent of participants that self-report of treatment completion

Secondary

MeasureTime frameDescription
Change in Food Insecurity ScoreBaseline and 6 month follow-upUsing the Food Insecurity Assessment: a 2 Question Hunger Vital Signs will be used to assess patient food insecurity status with the following two questions: "Within the past 12 months, did you worry your food would run out before you got the money to buy more?" "Within the past 12 months, did the food you buy not last and you didn't have money to get more?" Scoring will categorize patients as never true, sometimes true, or often true. Baseline is defined as when a patient responds SOMETIMES TRUE or OFTEN TRUE to one of the two validated Hunger Vital Sign Screening questions for the first time. Patients will receive an email about the financial impact and QOL validated surveys at each time interval.
Change in Quality of Life (QOL) using European Organisation for Research and Treatment of Cancer Core Quality of Life questionnaire (EORTC QLQ-30)Baseline and 6 month follow-upThe EORTC QLQ-30 questionnaire is a 30-item, patient-reported instrument designed to assess the health-related quality of life (HRQoL), functional status, and symptom burden of cancer patients. Comprises 30 questions grouped into 5 functional scales, 9 symptom scales/items, and a global health status. Scoring: Uses a 4-point Likert scale (7-point for global items), transformed to a 0-100 scale. Higher scores indicate better function/QoL, but worse symptom burden.
Change in financial toxicityBaseline and 6 month follow-upThe Functional Assessment of Chronic Illness Therapy for measure of financial toxicity (FACIT-COST) questionnaire to assess the impact of treatment on patient financial status. This measure has 12 questions based on patient reported outcomes to assess financial quality of life stress; numeric responses 0-4; Uses a score range 0-44 with higher scores indicating better Financial Well-Being.

Countries

United States

Contacts

CONTACTMassey CTO CPC Team
MasseyCPC@vcu.edu804-628-6430
PRINCIPAL_INVESTIGATORSusan Hong, MD

Virginia Commonwealth University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026